NCT07143071View on ClinicalTrials.gov

EndoVascular Aortic Dissection Early vs Delayed

Active, not recruitingOBSERVATIONAL
Enrollment

4,068

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

July 31, 2028

Study Completion Date

July 31, 2030

Conditions
Aortic Dissection Type B
Interventions
PROCEDURE

Acute Phase

Patients with acute high-risk type B aortic dissection received endovascular treatment in acute phase (2-14days)

PROCEDURE

Subacute Phase

Patients with acute high-risk type B aortic dissection received endovascular treatment in subacute phase (≥14days)

Trial Locations (1)

200032

Shanghai Zhongshan Hospital, Shanghai

All Listed Sponsors
lead

Shanghai Zhongshan Hospital

OTHER

NCT07143071 - EndoVascular Aortic Dissection Early vs Delayed | Biotech Hunter | Biotech Hunter